SEARCH
Subscribe
Track all markets on TradingView

Canadian Cannabis Stocks with Appealing Latin American Assets

Published:

Reading time: 7 min.

The Canadian cannabis stocks on our list could be tempting takeover targets as the major players make investments in South American cannabis cultivators

SmallCapPower | September 11, 2018: Aurora Cannabis Inc. (TSX:ACB) Monday announced an agreement to acquire ICC Labs Inc. (TSXV:ICC), a Uruguay/Colombia cannabis producer, in an all-stock deal valued at $290M. The news mirrors similar acquisitions by major cannabis companies seeking cultivation assets in the favourable equatorial climates of South America. Today, we have identified some Canadian cannabis stocks with cultivation facilities (in development or operating) located in Latin America that represent prime takeover targets for the major players within the cannabis industry.

For Our Complete Coverage Of Canadian Marijuana Stocks Click Here    

Watch: Cannex Capital Holdings (CSE:CNNX) Wants to Emerge as a Multi-State U.S. Player, Says CEO 

Khiron Life Sciences Corp. (TSXV:KHRN) – $1.07
Cannabis

Khiron Life Sciences is a Canadian medical cannabis company with operations in Colombia. The Company is focused on scientific and medical-based research applications for cannabis. Khiron estimates a potential market of 6M for patients in Colombia, with the intention of targeting an estimated 68M patients throughout Latin America upon future expansion. In 2017, Khiron was grated cultivation and production licenses in Colombia for both low and high THC strains. The Company intends to open its first clinics in Q4/2018.

  • Market Cap: $52.0 Million
  • 1 Month Total Return: 4.9%
  • Avg Volume last 30 days: 350,050
  • Avg Volume last 12 months: 110,931

Cronos Group Inc. (TSX:CRON) – $15.80
Cannabis

Cronos Group owns and operates two licensed producers of medical marijuana in Canada: Peace Naturals (medical) and In the Zone (recreational). The domestic capacity is expected to reach over 40,000KG prior to 2019. Internationally, the Company has formed a 50/50 joint venture with Agroidea SAS (AGI), Colombia’s leading agricultural service provider. The partnership permit Cronos to develop, cultivate, and manufacture cannabis at a custom-built, 207-acre facility, in Cundinamarca, Colombia.

  • Market Cap: $2,795.1 Million
  • 1 Month Total Return: 113.2%
  • Avg Volume last 30 days: 3,312,843
  • Avg Volume last 12 months: 1,250,896

MYM Nutraceuticals Inc. (CSE:MYM) – $1.28
Cannabis

MYM Nutraceuticals is a Canada-based company engaged in cannabis cultivation with production facilities in Canada, Australia, and Colombia. In Colombia, the Company owns a 49% stake in Colombia ORGANICA, which focuses on cultivating cannabis in the high altitude, equatorial regions of Antioquia. On August 8, 2018, the Company announced an agreement with Dutch Passion Seed Company to produce and distribute Dutch Passion branded cannabis products in Colombia.

  • Market Cap: $145.6 Million
  • 1 Month Total Return: 17.4%
  • Avg Volume last 30 days: 547,729
  • Avg Volume last 12 months: 1,367,621

Scythian Biosciences Corp. (CSE:SCYB) – $3.08
Cannabis

Scythian Biosciences is a research and development company focused on treating traumatic brain injury using cannabinoid-based drug therapy. Recently, the Company has initiated international expansion by forming strategic partnerships with cannabis cultivators in North America, South America, and the Caribbean. On August 8, 2018, Scythian announced that it had acquired 90% of Colcanna SAS, a Colombian-based company with a license to cultivate and import THC and CBD within Colombia.

  • Market Cap: $113.1 Million
  • 1 Month Total Return: -11.7%
  • Avg Volume last 30 days: 181,542
  • Avg Volume last 12 months: 207,576

PharmaCielo Ltd. (Not Yet Listed) (TSXV:AAJ.P)
Cannabis

PharmaCielo is a privately-held cannabis company focused on producing cannabis oil extracts and related cannabis products. Although the Company’s headquarters are in Canada, cultivation facilities are focused in Colombia due to favourable climate conditions. PharmaCielo gained its cannabis cultivation license in October 2017 and is currently commencing cultivation and processing of cannabis oil products. On August 13, 2018, the Company announced the closing of its private placement offering with gross proceeds being estimated at $39.2M. The Company is expected to go public via a Qualifying Transaction with capital pool company AAJ Capital 1 Corp. (TSXV:AAJ.P).
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below:

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
test28872674
test28872674

Related articles

Recent articles

© SmallCapPower 2024